Letter to the Editor
Targeting hepatic stellate cells may serve as a promising target for hepatic steatosis
Y Liu,
M Chen,
Y Liu
Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, China
Search for more papers by this authorCorresponding Author
M Chen
Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, China
Correspondence Mingkai Chen, Department of Gastroenterology, Renmin Hospital of Wuhan University, No. 99 Zhang Zhidong Road, Wuhan, Hubei 430000, China.
Email: [email protected]
Search for more papers by this authorY Liu,
M Chen,
Y Liu
Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, China
Search for more papers by this authorCorresponding Author
M Chen
Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, China
Correspondence Mingkai Chen, Department of Gastroenterology, Renmin Hospital of Wuhan University, No. 99 Zhang Zhidong Road, Wuhan, Hubei 430000, China.
Email: [email protected]
Search for more papers by this authorFirst published: 18 October 2022
No abstract is available for this article.
References
- 1Kawahara A, Kanno K, Yonezawa S, Otani Y, Kobayashi T, Tazuma S, Ito M. Depletion of hepatic stellate cells inhibits hepatic steatosis in mice. J. Gastroenterol. Hepatol. 2022; 37: 1946–1954.
- 2Kobayashi T, Kanno K, Nguyen PT et al. Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of non-alcoholic steatohepatitis. J. Gastroenterol. Hepatol. 2020; 35: 2140–2150.
- 3Kim BM, Abdelfattah AM, Vasan R, Fuchs BC, Choi MY. Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis. Sci. Rep. 2018; 8: 7499.
- 4Shmarakov IO, Jiang H, Liu J, Fernandez EJ, Blaner WS. Hepatic stellate cell activation: A source for bioactive lipids. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2019; 1864: 629–642.
- 5Yang A, Yan X, Fan X et al. Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice. Hepatol. Int. 2021; 15: 1122–1135.
- 6He Q, Xia X, Yao K et al. Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell. Life Sci. 2019; 239: 117010.
- 7Chu X, Jin Q, Chen H et al. CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading. J. Transl. Med. 2018; 16: 108.
- 8da Silva BD, Alberici LC, Ramos LF et al. Altered global microRNA expression in hepatic stellate cells LX-2 by angiotensin-(1-7) and miRNA-1914-5p identification as regulator of pro-fibrogenic elements and lipid metabolism. Int. J. Biochem. Cell Biol. 2018; 98: 137–155.
- 9Arab JP, Cabrera D, Sehrawat TS et al. Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12. J. Hepatol. 2020; 73: 149–160.
- 10Choi WM, Kim HH, Kim MH et al. Glutamate Signaling in Hepatic Stellate Cells Drives Alcoholic Steatosis. Cell Metab. 2019; 30: 877–89.e7.
